Alprazolam Tablets 2.0 mg Recalled for cGMP Deviations
ANI Pharmaceuticals is recalling Alprazolam Tablets, USP 2.0 mg nationwide due to current good manufacturing practice (cGMP) deviations. The recall affects approximately 70,788 bottles distributed throughout the United States.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II voluntary recall with no reported illnesses or injuries. The hazard (cGMP deviations) is a manufacturing/process concern rather than a specific product defect with direct harm potential, making it a precautionary recall typical of Moderate severity.
Plain-English summary
ANI Pharmaceuticals, Inc. is recalling Alprazolam Tablets, USP 2.0 mg packaged in 100-count bottles (NDC 67253-903-10) and 500-count bottles (NDC 67253-903-50), distributed nationwide within the United States. The recall was initiated due to cGMP deviations identified in the manufacturing process.
The affected product includes the following lot numbers and expiration dates: - 100-count bottles: Lot #19C002A (Exp. 03/2022), Lot #19E012A (Exp. 05/2022), Lot #19E013A (Exp. 05/2022) - 500-count bottles: Lot #19C100B (Exp. 04/2022), Lot #19E001B (Exp. 05/2022), Lot #19E002B (Exp. 05/2022)
Approximately 70,788 bottles have been distributed. The recall is voluntary and was initiated by the firm on February 15, 2022, and terminated on October 25, 2022. Consumers who have this medication should consult with their healthcare provider or pharmacist regarding their prescription before taking any action.
The recalled product
- Product
- Alprazolam Tablets, USP 2.0 mg, packaged in a) 100-count bottles (NDC 67253-903-10), b) 500-count bottles (NDC 67253-903-50), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977
- Manufacturer
- ANI Pharmaceuticals, Inc.
- Category
- Drug — Benzodiazepine
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot #: a) 19C002A
- Exp. Date 03/2022
- 19E012A
- 19E013A
- Exp. Date 05/2022. b) 19C100B
- Exp. Date 04/2022
- 19E001B
- 19E002B
- Exp. Date 05/2022.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27